vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.

PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $134.9M, roughly 1.6× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 10.9%, a 71.6% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs -5.5%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs -3.8%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

CTRE vs PLAB — Head-to-Head

Bigger by revenue
PLAB
PLAB
1.6× larger
PLAB
$210.4M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+60.6% gap
CTRE
55.1%
-5.5%
PLAB
Higher net margin
CTRE
CTRE
71.6% more per $
CTRE
82.5%
10.9%
PLAB
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
-3.8%
PLAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CTRE
CTRE
PLAB
PLAB
Revenue
$134.9M
$210.4M
Net Profit
$111.3M
$22.9M
Gross Margin
33.7%
Operating Margin
22.9%
Net Margin
82.5%
10.9%
Revenue YoY
55.1%
-5.5%
Net Profit YoY
113.5%
-32.4%
EPS (diluted)
$0.52
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
PLAB
PLAB
Q4 25
$134.9M
Q3 25
$132.4M
$210.4M
Q2 25
$112.5M
$211.0M
Q1 25
$96.6M
$212.1M
Q4 24
$86.9M
$222.6M
Q3 24
$77.4M
$211.0M
Q2 24
$68.9M
$217.0M
Q1 24
$63.1M
$216.3M
Net Profit
CTRE
CTRE
PLAB
PLAB
Q4 25
$111.3M
Q3 25
$74.9M
$22.9M
Q2 25
$68.5M
$8.9M
Q1 25
$65.8M
$42.9M
Q4 24
$52.1M
$33.9M
Q3 24
$33.4M
$34.4M
Q2 24
$10.8M
$36.3M
Q1 24
$28.7M
$26.2M
Gross Margin
CTRE
CTRE
PLAB
PLAB
Q4 25
Q3 25
33.7%
Q2 25
36.9%
Q1 25
35.6%
Q4 24
37.0%
Q3 24
35.6%
Q2 24
36.5%
Q1 24
36.6%
Operating Margin
CTRE
CTRE
PLAB
PLAB
Q4 25
Q3 25
58.1%
22.9%
Q2 25
61.3%
26.4%
Q1 25
24.6%
Q4 24
25.1%
Q3 24
43.0%
24.7%
Q2 24
15.1%
25.8%
Q1 24
26.6%
Net Margin
CTRE
CTRE
PLAB
PLAB
Q4 25
82.5%
Q3 25
56.6%
10.9%
Q2 25
60.9%
4.2%
Q1 25
68.1%
20.2%
Q4 24
60.0%
15.2%
Q3 24
43.2%
16.3%
Q2 24
15.6%
16.7%
Q1 24
45.6%
12.1%
EPS (diluted)
CTRE
CTRE
PLAB
PLAB
Q4 25
$0.52
Q3 25
$0.35
$0.39
Q2 25
$0.35
$0.15
Q1 25
$0.35
$0.68
Q4 24
$0.30
$0.54
Q3 24
$0.21
$0.55
Q2 24
$0.07
$0.58
Q1 24
$0.22
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
PLAB
PLAB
Cash + ST InvestmentsLiquidity on hand
$198.0M
$575.8M
Total DebtLower is stronger
$894.2M
$16.0K
Stockholders' EquityBook value
$4.0B
$1.1B
Total Assets
$5.1B
$1.8B
Debt / EquityLower = less leverage
0.22×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
PLAB
PLAB
Q4 25
$198.0M
Q3 25
$712.5M
$575.8M
Q2 25
$306.1M
$558.4M
Q1 25
$26.5M
$642.2M
Q4 24
$213.8M
$640.7M
Q3 24
$377.1M
$606.4M
Q2 24
$495.1M
$559.9M
Q1 24
$451.2M
$521.5M
Total Debt
CTRE
CTRE
PLAB
PLAB
Q4 25
$894.2M
Q3 25
$893.8M
$16.0K
Q2 25
$1.2B
$19.0K
Q1 25
$822.1M
$21.0K
Q4 24
$396.9M
$25.0K
Q3 24
$396.7M
$28.0K
Q2 24
$671.1M
$2.5M
Q1 24
$595.9M
$2.7M
Stockholders' Equity
CTRE
CTRE
PLAB
PLAB
Q4 25
$4.0B
Q3 25
$4.0B
$1.1B
Q2 25
$3.3B
$1.1B
Q1 25
$2.9B
$1.1B
Q4 24
$2.9B
$1.1B
Q3 24
$2.4B
$1.1B
Q2 24
$1.9B
$1.0B
Q1 24
$1.7B
$1.0B
Total Assets
CTRE
CTRE
PLAB
PLAB
Q4 25
$5.1B
Q3 25
$5.1B
$1.8B
Q2 25
$4.7B
$1.7B
Q1 25
$3.9B
$1.7B
Q4 24
$3.4B
$1.7B
Q3 24
$2.9B
$1.6B
Q2 24
$2.7B
$1.6B
Q1 24
$2.3B
$1.6B
Debt / Equity
CTRE
CTRE
PLAB
PLAB
Q4 25
0.22×
Q3 25
0.22×
0.00×
Q2 25
0.35×
0.00×
Q1 25
0.28×
0.00×
Q4 24
0.14×
0.00×
Q3 24
0.16×
0.00×
Q2 24
0.35×
0.00×
Q1 24
0.36×
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
PLAB
PLAB
Operating Cash FlowLast quarter
$394.0M
$50.1M
Free Cash FlowOCF − Capex
$25.2M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
3.54×
2.19×
TTM Free Cash FlowTrailing 4 quarters
$64.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
PLAB
PLAB
Q4 25
$394.0M
Q3 25
$100.9M
$50.1M
Q2 25
$100.8M
$31.5M
Q1 25
$71.4M
$78.5M
Q4 24
$244.3M
$68.4M
Q3 24
$67.2M
$75.1M
Q2 24
$53.0M
$76.5M
Q1 24
$48.8M
$41.5M
Free Cash Flow
CTRE
CTRE
PLAB
PLAB
Q4 25
Q3 25
$25.2M
Q2 25
$-29.1M
Q1 25
$43.3M
Q4 24
$25.2M
Q3 24
$50.7M
Q2 24
$56.5M
Q1 24
$-1.8M
FCF Margin
CTRE
CTRE
PLAB
PLAB
Q4 25
Q3 25
12.0%
Q2 25
-13.8%
Q1 25
20.4%
Q4 24
11.3%
Q3 24
24.0%
Q2 24
26.0%
Q1 24
-0.8%
Capex Intensity
CTRE
CTRE
PLAB
PLAB
Q4 25
Q3 25
11.8%
Q2 25
28.7%
Q1 25
16.6%
Q4 24
19.4%
Q3 24
11.6%
Q2 24
9.2%
Q1 24
20.0%
Cash Conversion
CTRE
CTRE
PLAB
PLAB
Q4 25
3.54×
Q3 25
1.35×
2.19×
Q2 25
1.47×
3.55×
Q1 25
1.08×
1.83×
Q4 24
4.68×
2.02×
Q3 24
2.01×
2.18×
Q2 24
4.92×
2.11×
Q1 24
1.70×
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

Related Comparisons